Clinical trial
S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III…
NCT00182611 · Kyoto University, Other · Completed
Key facts
| NCT number | NCT00182611 |
|---|---|
| Title | S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer |
| Official title | Phase III Clinical Study of Preoperative S-1/CDDP Combination Chemotherapy in Patients With Potentially Resectable Stage III Advanced Gastric Cancer |
| Lead sponsor | Kyoto University, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, tegafur-gimeracil-oteracil potassium, adjuvant therapy, conventional surgery, neoadjuvant therapy |
| Enrollment | 100 |
| Start date | Apr 1, 2004 |
| Primary completion | Sep 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 26, 2013 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: